TRADING UPDATES: East Star Verkhuba update; BSF distribution deal
11th Aug 2026 18:23
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 510.00p on 07-09-2026 at 09:00:00 |
|---|---|
| Change | -10.00p -1.92% |
| Buy | 518.00p |
| Sell | 490.50p |
| Last Trade: | Sell 48.00 at 480.50p |
| Day's Volume: | 14,406 |
| Last Close: | 520.00p |
| Open: | 495.50p |
| ISIN: | GB00BQVXM815 |
| Day's Range | 495.50p - 510.00p |
| 52wk Range: | 390.00p - 1,790.00p |
| Market Capitalisation: | £34.68m |
| VWAP: | 506.10819p |
| Shares in Issue: | 6.80m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 48 | 480.50p | SI Trade |
09:59:54 - 07-Sep-26 |
| Buy* | 500 | 510.00p | Automatic Execution |
09:59:54 - 07-Sep-26 |
| Buy* | 2,750 | 509.00p | Ordinary |
09:58:57 - 07-Sep-26 |
| Buy* | 53 | 500.00p | Ordinary |
09:15:29 - 07-Sep-26 |
| Buy* | 117 | 509.26p | Ordinary |
09:13:14 - 07-Sep-26 |
| Buy* | 1 | 510.00p | SI Trade |
09:12:05 - 07-Sep-26 |
| Buy* | 116 | 499.61p | Ordinary |
09:11:35 - 07-Sep-26 |
| Buy* | 724 | 500.00p | Ordinary |
09:06:29 - 07-Sep-26 |
| Buy* | 5 | 500.00p | SI Trade |
09:04:24 - 07-Sep-26 |
| Sell* | 9 | 480.50p | SI Trade |
09:04:24 - 07-Sep-26 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Sep 2026 7:00 am | RNS | Exercise of Warrants and Issue of Equity |
| 11th Aug 2026 7:00 am | RNS | Collaboration with Cellin Technologies |
| 29th Jul 2026 7:00 am | RNS | Collaboration and Company Update |
| 1st Jul 2026 7:00 am | RNS | Result of AGM |
| 5th Jun 2026 7:00 am | RNS | Notice of AGM |
| 29th May 2026 9:18 am | RNS | Grant of Options and Extension of Warrant Term |
| 30th Apr 2026 4:04 pm | RNS | Final Results |
| 28th Apr 2026 7:00 am | RNS | Institutional Fundraise |
| 14th Apr 2026 7:00 am | RNS | Annual IND Report with FDA |
| 31st Mar 2026 1:22 pm | RNS | Tech Transfer Completion and Clinical Trial Update |